Home › Calculator › NUVB Dividend Calculator 2026
NUVB Dividend DRIP Calculator 2026
35.09% YieldHealthcareNuvation Bio Inc. · NYSE
Price: $5.70 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When NUVB pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your NUVB snowball 📈
$10,000 in NUVB → $202.4K in 10 years · $4,380.43/month
About Nuvation Bio Inc. (NUVB) — Dividend Analysis 2026
Nuvation Bio Inc. functions as a clinical-stage biopharmaceutical enterprise committed to discovering and advancing therapeutic solutions for oncological conditions. Its foremost experimental compound, NUV-422, is a small molecule designed to inhibit cyclin-dependent kinases (CDK)2, CDK4, and CDK6. The company's development pipeline further encompasses NUV-868, an orally administered, selective small molecule BET inhibitor that epigenetically influences proteins critical for tumor proliferation and cellular differentiation; NUV-569, a unique oral small molecule targeting the Wee1 kinase to facilitate DNA damage repair; and NUV-1182, an antagonist of adenosine receptors. Additionally, Nuvation Bio is progressing a sophisticated drug-drug conjugate (DDC) platform, engineered to deliver a poly ADP ribose polymerase (PARP) inhibitor in conjunction with existing anti-cancer warheads, particularly for the treatment of ER-positive breast and ovarian cancers. Established in 2018, the firm was initially named RePharmation Inc. before rebranding as Nuvation Bio Inc. in April 2019, and its central operations are based in New York, New York.
Compare NUVB with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full NUVB DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open NUVB position with:
🌍 NUVB Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold NUVB.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 35.09% | 32.29% | $3,509 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 29.83% | 27.03% | $2,983 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 28.07% | 25.27% | $2,807 / yr |
| 🇬🇧 UK ISA | 0% | 35.09% | 32.29% | $3,509 / yr |
| 🇬🇧 UK Taxable | 8.75% | 32.02% | 29.22% | $3,202 / yr |
| 🇨🇦 TFSA | 0% | 35.09% | 32.29% | $3,509 / yr |
| 🇨🇦 CA Taxable | 25% | 26.32% | 23.52% | $2,632 / yr |
| 🇦🇺 Super (pension) | 15% | 29.83% | 27.03% | $2,983 / yr |
| 🇦🇺 AU Taxable | 30% | 24.56% | 21.76% | $2,456 / yr |
| 🇩🇪 DE Taxable | 26.375% | 25.84% | 23.04% | $2,584 / yr |
| 🇫🇷 FR Taxable | 30% | 24.56% | 21.76% | $2,456 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 NUVB Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 NUVB Dividend Payment Schedule
NUVB pays quarterly — 4 times per year. Next ex-div: TBD.
📊 NUVB vs Healthcare Benchmarks
How NUVB compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for NUVB sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ NUVB Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| M-Exempt | 2026-07-15 | 39,999 | $2.17 | $86.8K | ||
| M-Exempt | 2026-07-15 | 1 | $1.97 | $2.00 | ||
| M-Exempt | 2026-07-15 | 1 | $1.97 | $2.00 | ||
| M-Exempt | 2026-07-15 | 39,999 | $2.17 | $86.8K | ||
| M-Exempt | 2026-06-23 | 90,380 | $1.87 | $169.0K | ||
| M-Exempt | 2026-06-23 | 34,620 | $1.74 | $60.2K | ||
| M-Exempt | 2026-06-23 | 34,620 | $1.74 | $60.2K | ||
| M-Exempt | 2026-06-23 | 90,380 | $1.87 | $169.0K | ||
| Sale | 2026-06-23 | 125,000 | $6.03 | $753.2K | ||
| M-Exempt | 2026-06-23 | 63,000 | $2.93 | $184.6K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Geographic Revenue Breakdown
Where NUVB earns its moneyRevenue breakdown from latest annual report via FMP. Percentages may not sum to 100% due to rounding.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the NUVB dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Nuvation Bio Inc. (NUVB) is currently trading at $5.70, 58% below its 52-week high. The current dividend yield is 35.09% based on an annual payout of $2.00 per share.
NUVB (Nuvation Bio Inc.) — 35.09% Dividend Yield Analysis
Nuvation Bio Inc. (NUVB) is a healthcare stock currently trading at $5.70 with a dividend yield of 35.09%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (35.09%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.